Page last updated: 2024-08-26

equol and B16 Melanoma

equol has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Kamachi, S; Komatsu, S; Kumazoe, M; Lin, I; Murata, M; Oka, C; Tachibana, H; Yamashita, S	1

Other Studies

1 other study(ies) available for equol and B16 Melanoma

Article	Year
Soy isoflavone metabolite equol inhibits cancer cell proliferation in a PAP associated domain containing 5-dependent and an estrogen receptor-independent manner. The Journal of nutritional biochemistry, 2022, Volume: 100 Topics: Cell Line, Tumor; Cell Proliferation; Equol; Estrogen Receptor alpha; HeLa Cells; Humans; Isoflavones; MCF-7 Cells; Melanoma, Experimental; MicroRNAs; Neoplasm Transplantation; Receptors, Estrogen; RNA Nucleotidyltransferases; RNA, Small Nucleolar	2022

Article

Year

Soy isoflavone metabolite equol inhibits cancer cell proliferation in a PAP associated domain containing 5-dependent and an estrogen receptor-independent manner.

The Journal of nutritional biochemistry, 2022, Volume: 100

Topics: Cell Line, Tumor; Cell Proliferation; Equol; Estrogen Receptor alpha; HeLa Cells; Humans; Isoflavones; MCF-7 Cells; Melanoma, Experimental; MicroRNAs; Neoplasm Transplantation; Receptors, Estrogen; RNA Nucleotidyltransferases; RNA, Small Nucleolar

2022